Radiation-induced Myocardial Injury in a Breast Cancer Patient.

Radiation-induced Myocardial Injury in a Breast Cancer Patient. Intern Med. 2020 Oct 07;: Authors: Minami T, Kawano H, Sueyoshi E, Maemura K PMID: 33028777 [PubMed - as supplied by publisher]
Source: Internal Medicine - Category: Internal Medicine Tags: Intern Med Source Type: research

Related Links:

ConclusionAPBI with SBRT and ExacTrac Adaptive Gating System was feasible. The acute and late toxicities were almost null and cosmesis was excellent. We also found that the margins of 5  mm applied from CTV to PTV were sufficient to compensate for geometric uncertainties.
Source: Clinical and Translational Oncology - Category: Cancer & Oncology Source Type: research
1. DCISM patients had a good survival, even those with DCIS component ≥5 cm.2. Patients aged
Source: Cancer Medicine - Category: Cancer & Oncology Authors: Tags: RESEARCH ARTICLE Source Type: research
Women who undergo radiation therapy to the left side of the chest to treat breas...Read more on AuntMinnie.comRelated Reading: DBT screening shows value in community practice settings Synthesized mammo plus DBT handles calcifications differently Immediately reading mammograms helps with workflow, disparities Use of MRI-directed ultrasound called into question Spectral mammography as good as MRI for breast cancer evaluation
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news
Call for a Move or Boycott of Big Texas Cancer Meeting Oncologists are calling for this year's San Antonio Breast Cancer Symposium to be moved out of Texas in response to the state's new abortion law, and a boycott of in-person attendance if no move happens. www.medscape.com The funny thing is that they are not proposing a true boycott, just planning to attend on-line rather than in-person. That type of "protest" won't fly with ASTRO as there is no discount for attending online anyway so they get paid the same regardless.
Source: Student Doctor Network - Category: Universities & Medical Training Authors: Tags: Radiation Oncology Source Type: forums
Condition:   Can the Geriatric Questionnaires Predict Adverse Effects in Geriatric Breast Cancer Patients Treated With Cyclin-dependent Kinase 4 and 6 Inhibitors Intervention:   Drug: Palbociclib 125mg and Ribociclib 600 mg Sponsor:   Namik Kemal University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Breast Cancer Interventions:   Other: Intervention plus 12 months maintenance;   Other: Intervention plus 10 months maintenance;   Other: Intervention plus 8 months maintenance;   Other: Intervention plus 6 months maintenance;   Other: Intervention plus 4 months maintenance Sponsor:   Vanderbilt University Medical Center Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
AbstractObjectivesTo prospectively evaluate the diagnostic performance of screening ABUS as the primary screening test for breast cancer among Korean women aged 40 –49 years.MethodsThis prospective, multicenter study included asymptomatic Korean women aged 40 –49 years from three academic centers between February 2017 and October 2019. Each participant underwent ABUS without mammography, and the ABUS images were interpreted at each hospital with double-reading by two breast radiologists. Biopsy and at least 1 year of follow-up was considered the refere nce standard. Diagnostic performance of ABUS screening and ...
Source: European Radiology - Category: Radiology Source Type: research
We present an ER-negative case of metastatic ILC presenting as linitis plastica of the colon where [18F]FES PET/MRI allowed the evaluation of the ER phenotypic transformation in the colonic metastasis from the ER-positive breast ILCin  vivo.
Source: Journal of Medical Imaging and Radiation Oncology - Category: Radiology Authors: Tags: Medical Imaging —Case Letter Source Type: research
New results show a survival benefit in a subgroup of women with triple-negative breast cancer (TNBC) when pembrolizumab (Keytruda) is added to chemotherapy.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
CONCLUSIONS: Non-genomic phenotypic adaptations at metastatic sites are critical to BM progression and patients' prognosis. This study opens the road to use IL13Rα2-targeting as a therapeutic strategy for BM.PMID:34544797 | DOI:10.1158/1078-0432.CCR-21-0361
Source: Clinical Cancer Research - Category: Cancer & Oncology Authors: Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Internal Medicine